BioSpace News Archive

This is the first presentation of the pooled analyses and builds on the individual positive results of the Phase 2 and Phase 3 clinical studies.

The first white paper outlines the results of a survey completed by ACRO members.

Preference for treatment using therapeutics will drive market growth in North America

Demonstrates Industry Leadership and Commitment to Patient Experience

A new study released today at the 89th Annual Meeting of the American Thyroid Association (ATA) calls into question the pharmacy practice of creating custom made thyroid hormone formulations for individual patients.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based DNA manufacturing for product authenticity and traceability solutions, announced today that it will effect a 1-for-40 reverse split of its outstanding common stock effective at 12:01 AM Eastern Time on Friday, November 1, 2019

Mindstrong Health, a healthcare innovation company dedicated to transforming mental health through innovations in digital measurement and virtual care models, today announced that Daniel Graf, a veteran technologist and leader of key product teams at Uber, Twitter and Google, has been appointed CEO

When the world’s largest radiologic science association wanted to spread the word about the dedicated health care professionals who perform medical imaging and radiation therapy procedures, it didn’t employ national television or digital billboards. It turned to public libraries.

$116 million raised to support new professorships and chairs to accelerate academic, research and clinical innovation

Maxar Technologies (NYSE:MAXR) (TSX:MAXR), a trusted partner and innovator in Earth Intelligence and Space Infrastructure, today announced that its stockholders voted in favor of the Company’s Tax Benefit Preservation Plan.